About 30% of dermatomyositis cases in adults are associated with malignancy, whereas up to 50%-75% of dermatomyositis cases in cancer patients are found to have positive serum anti-TIF1γ antibodies [6]. The gene discussed is TRIM33; the disease is cancer.